MHLW Approves Three Medical Devices
This article was originally published in PharmAsia News
Executive Summary
The medical device and in vitro diagnostic committee at the Pharmaceutical Affairs and Food Sanitation Council of Japan's Ministry of Health, Labor and Welfare approved three products. They are Japan Lifeline's PDA Closure Set to be used to treat patent ductus arteriosus, andSynthes' Veptr System, which is used totreat congenital spine and thorax deformities. The committee also approved an additional indication for Nidek's Excimer Leser EC-5000 to correct far sightedness. (Click here for more - Japanese language
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.